Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Amyloid precursor protein (), presenilin 1 (), and presenilin 2 () are associated with autosomal-dominant early-onset Alzheimer's disease (AD). Most mutations have been identified in the gene. We discovered a mutation (Tyr389His) in a Korean patient with early-onset AD who presented memory decline at 41 years of age followed by language, memory, and visuospatial dysfunctions. As this is the third such patient identified in Korea, this mutation may be involved in AD pathogenesis, suggesting that routine screening is necessary in this population. Altered intra-molecular interactions with the mutated amino acid may result in the destabilization of γ-secretase. In the future, a panel incorporating genes with relatively high-frequency rare variants, along with the gene, may predict the onset of AD and facilitate customized treatment.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781446 | PMC |
| http://dx.doi.org/10.3390/ijms232416192 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background Over 300 mutations in have been identified as causes of early-onset Alzheimer's disease (EOAD). While these include missense mutations and a few insertions, deletions, or duplications, none result in open reading frame shifts, and all alter γ-secretase function to increase the long/short Aβ ratio. Methods We identified a novel heterozygous nonsense variant, c.
View Article and Find Full Text PDFDown syndrome and a presenilin 2 variant: dual genetic risk of Alzheimer's disease.
Acta Neuropathol
September 2025
Department of Laboratory Medicine and Pathology, University of Washington, 325 9th Ave, Seattle, WA, 98104, USA.
Early onset familial Alzheimer's disease (EOFAD) is rare compared to sporadic AD, but dominant variants in genes involved in amyloid β (Aβ) processing are well-described. One such variant is in the presenilin 2 (PSEN2) gene, N141I, and was first described in a family with Volga German descent. Separately, individuals with Down syndrome (DS) are also at risk for early onset AD, having an extra copy of an amyloid precursor protein gene.
View Article and Find Full Text PDFClinical profile of early-onset Alzheimer's disease in Peru: case series from a neurological care center.
Rev Peru Med Exp Salud Publica
August 2025
Centro Básico de Investigación en Demencias y Enfermedades Desmielinizantes del Sistema Nervioso, Instituto Nacional de Ciencias Neurológicas, Lima, Perú.
Background: Motivation for the study. To describe the clinical characteristics of early-onset Alzheimer's disease (EOAD) and compare them according to gender. This condition is considered a rare disease, whose manifestations are still poorly understood.
View Article and Find Full Text PDFA rare intronic c.2654+1G>A mutation in CSF1R-microglial encephalopathy: a case report.
Front Genet
August 2025
Department of Neurology, First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine, Guiyang, China.
Objective: We report a case of CSF1R-microglial encephalopathy associated with a rare intronic c.2654 + 1G>A mutation, featuring negative diffusion-weighted imaging (DWI) findings and a cerebrospinal fluid (CSF) biomarker profile indicative of Alzheimer's disease-related changes, and we explore the associations between genetic mutations, CSF biomarker alterations, and neuroimaging manifestations.
Methods: This study documents the demographic data, detailed medical history, and clinical manifestations of a patient with CSF1R-microglial encephalopathy.
Objective physical activity in people with young onset dementia, late onset dementia, and without dementia: A UK Biobank study.
J Alzheimers Dis
September 2025
UC Research Institute for Sport and Exercise, University of Canberra, Canberra, ACT, Australia.
BackgroundCurrent physical activity literature does not distinguish between young (dementia diagnosed before 65) and late onset dementia despite differences between these groups such as age, being known to influence physical activity levels.ObjectiveThe primary aim was to compare objective physical activity levels between people with young onset dementia, late onset dementia, and age-matched control participants without dementia.MethodsThis cross-sectional analysis included four groups (young onset dementia [n = 23]; young onset control [n = 782]; late onset dementia [n = 30]; late onset control [n = 918]) of participants aged 49 to 76 (56% male) from the UK Biobank.
View Article and Find Full Text PDF